Literature DB >> 24924804

Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat.

Michelle Healy-Stoffel1, S Omar Ahmad2, John A Stanford3, Beth Levant4.   

Abstract

The midbrain dopaminergic perikarya are differentially affected in Parkinson׳s disease (PD). This study compared the effects of a partial unilateral intrastriatal 6-hydroxydopamine (6-OHDA) lesion model of PD on the number, morphology, and nucleolar volume of dopaminergic cells in the substantia nigra pars compacta (SNpc), ventral tegmental area (VTA), and retrorubral field (RRF). Adult, male rats (n=10) underwent unilateral intrastriatal infusion of 6-OHDA (12.5μg). Lesions were verified by amphetamine-stimulated rotation 7 days post-infusion. Rats were euthanized 14 days after treatment with 6-OHDA and brains were stained with a tyrosine hydroxylase-silver nucleolar (TH-AgNOR) stain. Dopaminergic cell number and morphology in the lesioned and intact hemispheres were quantified using stereological methods. The magnitude of decrease in planimetric volume, neuronal number, cell density, and neuronal volume resulting from 6-OHDA lesion differed between regions, with the SNpc exhibiting the greatest loss of neurons (46%), but the smallest decrease in neuronal volume (13%). The lesion also resulted in a decrease in nucleolar volume that was similar in all three regions (22-26%). These findings indicate that intrastriatal 6-OHDA lesion differentially affects dopaminergic neurons in the SNpc, VTA, and RRF; however, the resulting changes in nucleolar morphology suggest a similar cellular response to the toxin in all three cell populations.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  6-hydroxydopamine; Dopamine; Retrorubral field; Stereology; Substantia nigra; Ventral tegmental area

Mesh:

Substances:

Year:  2014        PMID: 24924804      PMCID: PMC4115364          DOI: 10.1016/j.brainres.2014.05.045

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  42 in total

1.  Axonal sprouting following lesions of the rat substantia nigra.

Authors:  D I Finkelstein; D Stanic; C L Parish; D Tomas; K Dickson; M K Horne
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  The efficiency of systematic sampling in stereology--reconsidered.

Authors:  H J Gundersen; E B Jensen; K Kiêu
Journal:  J Microsc       Date:  1999-03       Impact factor: 1.758

3.  Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.

Authors:  Vânia Gomide; Theo Bibancos; Gerson Chadi
Journal:  Int J Neurosci       Date:  2005-04       Impact factor: 2.292

4.  Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat.

Authors:  C S Lee; H Sauer; A Bjorklund
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

5.  Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy.

Authors:  D E Smith; J Roberts; F H Gage; M H Tuszynski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

6.  Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.

Authors:  D A McRitchie; H R Cartwright; G M Halliday
Journal:  Exp Neurol       Date:  1997-03       Impact factor: 5.330

7.  The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.

Authors:  D C German; E L Nelson; C L Liang; S G Speciale; C M Sinton; P K Sonsalla
Journal:  Neurodegeneration       Date:  1996-12

8.  Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

Authors:  D Kirik; C Rosenblad; A Björklund
Journal:  Exp Neurol       Date:  1998-08       Impact factor: 5.330

9.  Differential time- and dose-related effects of haemorrhage on tyrosine hydroxylase and neuropeptide Y mRNA expression in medullary catecholamine neurons.

Authors:  R K Chan; P E Sawchenko
Journal:  Eur J Neurosci       Date:  1998-12       Impact factor: 3.386

Review 10.  Early diagnosis of Parkinson's disease.

Authors:  Georg Becker; Antje Müller; Stefan Braune; Thomas Büttner; Reiner Benecke; Wolfgang Greulich; Wolfgang Klein; Günter Mark; Jürgen Rieke; Reiner Thümler
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

View more
  8 in total

1.  Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Authors:  Zahra Kiasalari; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Cell Mol Neurobiol       Date:  2015-06-29       Impact factor: 5.046

2.  SMER28 Attenuates Dopaminergic Toxicity Mediated by 6-Hydroxydopamine in the Rats via Modulating Oxidative Burdens and Autophagy-Related Parameters.

Authors:  Shahram Darabi; Ali Noori-Zadeh; Farzad Rajaei; Hojjat Allah Abbaszadeh; Salar Bakhtiyari; Navid Ahmady Roozbahany
Journal:  Neurochem Res       Date:  2018-10-04       Impact factor: 3.996

3.  Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.

Authors:  Zahra Kiasalari; Mohsen Khalili; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Neurochem Res       Date:  2015-12-23       Impact factor: 3.996

4.  Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.

Authors:  Nicole K Polinski; Terina N Martinez; Alexander Gorodinsky; Ralph Gareus; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Mali Cosden; Monika Kandebo; Robert E Drolet; Peter D Buckett; Weisong Shan; Yi Chen; Lee J Pellegrino; Gregory D Ellsworth; Leo B Dungan; Warren D Hirst; Sean W Clark; Kuldip D Dave
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

5.  Spontaneous Graft-Induced Dyskinesias Are Independent of 5-HT Neurons and Levodopa Priming in a Model of Parkinson's Disease.

Authors:  Emma L Lane; David J Harrison; Elena Ramos-Varas; Rachel Hills; Sophie Turner; Mariah J Lelos
Journal:  Mov Disord       Date:  2021-11-12       Impact factor: 9.698

6.  The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models.

Authors:  Nicole K Polinski; Terina N Martinez; Sylvie Ramboz; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Lee J Pelligrino; Sean W Clark; Jacob N Marcus; Sean M Smith; Kuldip D Dave; Mark A Frasier
Journal:  Dis Model Mech       Date:  2022-05-25       Impact factor: 5.732

7.  Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein.

Authors:  Eduard Bentea; Anke Van der Perren; Joeri Van Liefferinge; Anissa El Arfani; Giulia Albertini; Thomas Demuyser; Ellen Merckx; Yvette Michotte; Ilse Smolders; Veerle Baekelandt; Ann Massie
Journal:  Front Behav Neurosci       Date:  2015-03-31       Impact factor: 3.558

8.  A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.

Authors:  Laura Louise Scott; Timothy Grant Downing
Journal:  Toxins (Basel)       Date:  2017-12-29       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.